Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-11-020044)

Filing Details

Accession Number:: 0001209191-11-020044
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2011-03-29 18:54:43
Reporting Period:: 2011-03-25

Filing Date:: 2011-03-29
Accepted Time:: 2011-03-29 18:54:43
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1107332	Dendreon Corp	DNDN	Pharmaceutical Preparations (2834)	223203193

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1242882	Mitchell Gold	3005 First Avenue Seattle WA 98121	President & Chief Executive Of	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2011-03-25	19,000	$4.90	308,801	No	4	M	Direct
Common Stock	Disposition	2011-03-25	19,000	$33.21	289,801	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Non-Qualified Stock Option (right to buy)	Disposition	2011-03-25	19,000	$33.21	19,000	$4.90

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
52,150		2017-12-05	No	4	M	Direct

Footnotes

The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
These options vest as follows: 25% of the total number of shares on the first anniversary date and, thereafter, at a rate of 1/36 of the total number of shares in equal monthly installments.